Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Preliminary results
Quarterly results

MARAVAI LIFESCIENCES HOLDINGS, INC. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 4 MARTIN WILLIAM E. III (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 300,000 rights @ $0
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS"
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT",
"Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition William “Trey” Martin, III assumes the role of Maravai’s CEO Carl Hull to continue to serve as Executive Chairman"
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/20/2023 8-K Quarterly results
07/19/2023 4 Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 874 shares @ $11.72, valued at $10.2k
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Dolan Christine (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 1,394 shares @ $11.72, valued at $16.3k
07/19/2023 4 Hopfield Jessica (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 24,000 shares @ $0
07/19/2023 4 Leddy Peter Michael (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 1,920 shares @ $11.72, valued at $22.5k
Paid exercise price by delivering 5,578 shares @ $12.52, valued at $69.8k
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Ashkenazi Anat (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 24,000 shares @ $0
07/19/2023 4 LUCIER GREGORY T (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 24,000 shares @ $0
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 MIHAS CONSTANTINE S (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 24,000 shares @ $0
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS"
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/17/2023 4 ORESHACK KURT (General Counsel) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 38,386 shares @ $0
Granted 76,500 options to buy @ $15.52, valued at $1.2M
03/17/2023 4 Leddy Peter Michael (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 72,507 shares @ $0
Granted 143,000 options to buy @ $15.52, valued at $2.2M
03/17/2023 4 Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 72,507 shares @ $0
Granted 143,000 options to buy @ $15.52, valued at $2.2M
03/17/2023 4 Dolan Christine (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 55,775 shares @ $0
Granted 110,000 options to buy @ $15.52, valued at $1.7M
03/17/2023 4 HULL CARL (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns: Granted 147,638 shares @ $0
Granted 270,109 options to buy @ $15.52, valued at $4.2M
03/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS"
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 7.9% stake in Maravai LifeSciences Holdings Inc. Class A
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy